Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00466804 · ClinicalTrials.gov registry record
Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 263
- Enrollment target
NCT00466804: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00466804 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 263 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00466804 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 263 participants
- Enrollment target
Study Summary
Injury of transplant tissue by a transplant recipient's immune system continues to be the leading cause of graft rejection and recipient death. The purpose of this study is to identify a single test or a combination of noninvasive tests currently used for heart transplant monitoring that correlate to long-term graft survival.
Primary Outcome
A composite of incidence of the following: * Death, * Re-transplantation or re-listed for transplantation, * Biopsy proven acute rejection (BPAR) of \> 2R, * Episode of rejection associated with hemodynamic compromise, * Coronary artery vasculopathy defined by a change in MIT of \>0.5 mm between study entry and 12 months.
Interventions
- PROCEDURE Heart transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2007-06 |
| Est. Completion | 2011-07 |
What the finished NCT00466804 record still lists
NCT00466804 is an observational study that tracks outcomes without assigning an intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Heart transplant is the first listed.
NCT00466804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00466804 about?
NCT00466804 is a clinical study titled "Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients". Injury of transplant tissue by a transplant recipient's immune system continues to be the leading cause of graft rejection and recipient death. The purpose of this study is to identify a single test or a combination of noninvasive tests currently used for heart transplant monitoring that correlate t...
What is the current status of trial NCT00466804?
This trial is currently completed. The enrollment target is 263 participants. The study started on 2007-06. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00466804?
The interventions under investigation include: Heart transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00466804?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04067336 · 263 participants · Phase 1
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- NCT06234423 · 263 participants · Phase 1
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- NCT06724627 · 263 participants · NA
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
- NCT04101669 · 264 participants · NA
RESET System Pivotal Trial (Rev F)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia